Span-America Medical Director Sells $49,296 in Stock (SPAN)
Span-America Medical (NASDAQ:SPAN) Director Thomas D. Henrion sold 2,600 shares of the company’s stock on the open market in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $18.96, for a total transaction of $49,296.00. Following the sale, the director now directly owns 127,084 shares in the company, valued at approximately $2,409,513. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Separately, analysts at Sidoti downgraded shares of Span-America Medical from a “buy” rating to a “neutral” rating in a research note on Wednesday, August 6th.
Shares of Span-America Medical (NASDAQ:SPAN) opened at 19.60 on Monday. Span-America Medical has a one year low of $18.09 and a one year high of $25.02. The stock has a 50-day moving average of $19.85 and a 200-day moving average of $20.75. The company has a market cap of $58.1 million and a P/E ratio of 18.49.
Span-America Medical (NASDAQ:SPAN) last announced its earnings data on Monday, August 4th. The company reported $0.13 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.34 by $0.21. The company had revenue of $13.30 billion for the quarter, compared to the consensus estimate of $18.62 billion. Analysts expect that Span-America Medical will post $0.86 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Thursday, September 4th. Stockholders of record on Thursday, August 14th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 3.06%. The ex-dividend date is Tuesday, August 12th. This is a boost from Span-America Medical’s previous quarterly dividend of $0.14.
Span-America Medical Systems, Inc manufactures and distributes a variety of therapeutic support surfaces and related products utilizing polyurethane and other foam products for the medical, consumer and industrial markets.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.